CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-15 | Risser Eric Blasius Chief Operating Officer | Grant or award · Employee stock option (right to buy) | +200,000 | 200,000 | ||
| 2023-02-15 | Risser Eric Blasius Chief Operating Officer | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2023-02-15 | Cilinski Lynn VP, Controller and Treasurer | Grant or award · Employee stock option (right to buy) | +75,000 | 75,000 | ||
| 2023-02-15 | Cilinski Lynn VP, Controller and Treasurer | Grant or award · Restricted Stock Unit | +20,000 | 20,000 | ||
| 2023-02-15 | Karrels James SVP, CFO and Secretary | Grant or award · Employee stock option (right to buy) | +180,000 | 180,000 | ||
| 2023-02-15 | Karrels James SVP, CFO and Secretary | Grant or award · Restricted Stock Unit | +45,000 | 45,000 | ||
| 2023-02-15 | Eck Stephen L. Chief Medical Officer | Grant or award · Employee stock option (right to buy) | +200,000 | 200,000 | ||
| 2023-02-15 | Eck Stephen L. Chief Medical Officer | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2023-02-14 | BIOTECH TARGET N V 10% owner | Purchase | +500,000 | $5.07 | $2.5M | 9,579,963 |
| 2023-01-19 | BIOTECH TARGET N V 10% owner | Purchase | +150,000 | $5.30 | $795K | 9,079,963 |
| 2023-01-03 | Chhabra Meenu Director | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2023-01-03 | Liu Margaret Director | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2022-12-27 | BIOTECH TARGET N V 10% owner | Purchase | +200,000 | $5.61 | $1.1M | 8,929,963 |
| 2022-12-23 | BIOTECH TARGET N V 10% owner | Purchase | +200,000 | $5.88 | $1.2M | 8,729,963 |
| 2022-11-22 | BIOTECH TARGET N V 10% owner | Purchase | +300,000 | $5.96 | $1.8M | 8,529,963 |
| 2022-10-28 | Risser Eric Blasius Chief Operating Officer | Exercise or conversion | +8,500 | $1.51 | $13K | 53,468 |
| 2022-10-28 | Risser Eric Blasius Chief Operating Officer | Exercise or conversion · Employee stock option (right to buy) | −8,500 | $1.51 | $13K | 0 |
| 2022-10-24 | BIOTECH TARGET N V 10% owner | Purchase | +250,000 | $4.36 | $1.1M | 8,229,963 |
| 2022-10-21 | BIOTECH TARGET N V 10% owner | Purchase | +250,000 | $4.63 | $1.2M | 7,979,963 |
| 2022-10-20 | BIOTECH TARGET N V 10% owner | Purchase | +285,977 | $4.00 | $1.1M | 7,729,963 |
Page 20 of 26 · 503 trades